Dr. Klein named chair of Cleveland Clinic’s Glickman Institute
Eric A. Klein, MD has been appointed chairman of the Glickman Urological and Kidney Institute at the Cleveland Clinic.
Eric A. Klein, MD has been appointed chairman of the Glickman Urological and Kidney Institute at Cleveland Clinic.
Dr. Klein, a leader in the biology and management of prostate cancer, served as interim chair of the institute following the death of previous chairman Andrew Novick, MD in October 2008. His clinical area of interest is urologic oncology, including cancers of the prostate, bladder, testis, and kidney.
“As a national and international expert in his field, Eric is well-positioned to further expand the institute’s reputation for medical and surgical advancements while fostering an environment of collaboration,” said Joseph Hahn, MD, Cleveland Clinic chief of staff. “Eric brings a wealth of medical and research experience and expertise to this position, which will benefit the highly ranked Glickman Urological and Kidney Institute.”
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.
